VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IWWM-11 2022 | The role of chemoimmunotherapy in Waldenström’s macroglobulinemia

In this video, Jorge Castillo, MD, Dana-Farber Cancer Institute, Boston, MA, briefly summarizes the role of chemoimmunotherapy in Waldenström’s macroglobulinemia (WM) in the era of novel targeted agents, and highlights the importance of combination approaches. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consulting fees or research funds from Abbvie, AstraZeneca, BeiGene, Casma, Cellectar, Janssen, Pharmcyclics, Roche, TG Therapeutics.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter